Alertix
The company develops and provides blood-based screening tests for the early detection and monitoring of cancer in companion animals, specifically dogs, cats, and horses. Their diagnostic method measures Serum TK1 to identify solid tumors and other malignancies through samples taken at veterinary clinics. The service is primarily targeted at pet owners and veterinarians seeking affordable screening for aging animals.
Healthtech
Veterinary Diagnostics
Biotechnology
Pet Care
Funding summary
- Total raised
- €370K
- Funding rounds
- 1
Investors in Alertix
Investors on record for Alertix. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Alertix?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors